systematic literature review economic implications pharmacoeconomic issues rheumatoid arthritis pubmed ncbi abstract objectives provide state art economic analyses applied rheumatoid arthritis ra methods systematic literature review economic consequences pharmacoeconomic issues ra performed results num valid articles examined review generally financial impact ra substantial health-care systems society worldwide differences exist national economies direct indirect i e loss productivity costs contribute economic burden ra account estimating impact society disease severity disease activity age socioeconomic status found relevant predictors cost increase ra introduction biological anti-rheumatic agents significantly raised direct medical costs patients led marked improvements reducing disease activity joint damage productivity loss patients ra significant impact aspects quality life recent publications health utility scores showed ra diseases poorest quality life conclusions ra represents clinical economic burden healthcare systems attributable ra costs extensively evaluated decades issues expensive therapies addressed frequently updated future research provide health economic evidence usual practice settings economic impact therapeutic approaches pursue specific clinical targets individual patients 
